These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 16698620)

  • 1. Screening of substance misuse during early pregnancy in Blyth: an anonymous unlinked study.
    Sanaullah F; Gillian M; Lavin T
    J Obstet Gynaecol; 2006 Apr; 26(3):187-90. PubMed ID: 16698620
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prevalence of chemical substance and alcohol abuse in an obstetric population in Dublin.
    Bosio P; Keenan E; Gleeson R; Dorman A; Clarke T; Darling M; O'Connor J
    Ir Med J; 1997; 90(4):149-50. PubMed ID: 9267096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of substance abuse in pregnancy among Danish women.
    Rausgaard NL; Ibsen IO; Jørgensen JS; Lamont RF; Ravn P
    Acta Obstet Gynecol Scand; 2015 Feb; 94(2):215-9. PubMed ID: 25366294
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Universal screening for substance abuse at the time of parturition.
    Azadi A; Dildy GA
    Am J Obstet Gynecol; 2008 May; 198(5):e30-2. PubMed ID: 18279831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drug abuse during pregnancy in an inner-city hospital: prevalence and patterns.
    Land DB; Kushner R
    J Am Osteopath Assoc; 1990 May; 90(5):421-6. PubMed ID: 2354963
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Perinatal screening for drugs of abuse: reassessment of current practice in a high-risk area.
    Schulman M; Morel M; Karmen A; Chazotte C
    Am J Perinatol; 1993 Sep; 10(5):374-7. PubMed ID: 8240597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors related to perinatal substance abuse in a California county.
    Gurnack AM; Paul W
    Percept Mot Skills; 1997 Jun; 84(3 Pt 2):1403-8. PubMed ID: 9229467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug screening during pregnancy: Urine dip cups measure up.
    Kroska EB; Meller EW; Doyle R; Coker JL; Knight BT; Ray-Griffith SL; Nembhard WN; Stowe ZN
    Drug Alcohol Depend; 2019 Nov; 204():107461. PubMed ID: 31521952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Community-wide estimation of illicit drug use in delivering women: prevalence, demographics, and associated risk factors.
    Vaughn AJ; Carzoli RP; Sanchez-Ramos L; Murphy S; Khan N; Chiu T
    Obstet Gynecol; 1993 Jul; 82(1):92-6. PubMed ID: 8515933
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of the prevalence of drug misuse by meconium analysis.
    Williamson S; Jackson L; Skeoch C; Azzim G; Anderson R
    Arch Dis Child Fetal Neonatal Ed; 2006 Jul; 91(4):F291-2. PubMed ID: 16790733
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prevalence of substance abuse among pregnant women in Utah.
    Buchi KF; Varner MW; Chase RA
    Obstet Gynecol; 1993 Feb; 81(2):239-42. PubMed ID: 8423958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of use of cocaine and other substances in an obstetric population.
    Matera C; Warren WB; Moomjy M; Fink DJ; Fox HE
    Am J Obstet Gynecol; 1990 Sep; 163(3):797-801. PubMed ID: 2403158
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anonymous cocaine screening in a private obstetric population.
    Burke MS; Roth D
    Obstet Gynecol; 1993 Mar; 81(3):354-6. PubMed ID: 8437785
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A descriptive regional study of drug and alcohol use in pregnant women using results from urine drug testing by liquid chromatography-tandem mass spectrometry.
    Kreshak A; Villano J; Clark A; Deak P; Clark R; Miller C
    Am J Drug Alcohol Abuse; 2016 Mar; 42(2):178-86. PubMed ID: 26811262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comparison of common practices for identifying substance use during pregnancy in obstetric clinics.
    Klawans MR; Northrup TF; Villarreal YR; Berens PD; Blackwell S; Bunag T; Stotts AL
    Birth; 2019 Dec; 46(4):663-669. PubMed ID: 30916432
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Psychoactive substance use during pregnancy: a review].
    Lamy S; Thibaut F
    Encephale; 2010 Feb; 36(1):33-8. PubMed ID: 20159194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prenatal substance use in a Western urban community.
    Buchi KF; Varner MW
    West J Med; 1994 Nov; 161(5):483-6. PubMed ID: 7810126
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Screening for substance abuse in pregnancy.
    Jimerson SD; Musick S
    J Okla State Med Assoc; 2013 Apr; 106(4):133-4. PubMed ID: 23795524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of exposure to drugs of abuse during pregnancy by hair analysis in a Mediterranean island.
    Friguls B; Joya X; Garcia-Serra J; Gómez-Culebras M; Pichini S; Martinez S; Vall O; Garcia-Algar O
    Addiction; 2012 Aug; 107(8):1471-9. PubMed ID: 22296208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Substance abuse in pregnancy.
    Feng T
    Curr Opin Obstet Gynecol; 1993 Feb; 5(1):16-23. PubMed ID: 8425031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.